$RBRK

Nithrakashyap Arvind sold $450K of RBRK

Nithrakashyap Arvind (Chief Technology Officer) sold 5,655 shares of Rubrik, Inc. (RBRK) at $79.56 ($0.45M total) on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Nithrakashyap Arvind
Published Jun 4, 2026, 1:39 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 4, 2026, 2:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RBRK
Neutral
medium confidence
Mentioned
$RBRK
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RBRKNeutralLow
01

Why it matters

The disclosure updates insider activity records; however, because it is explicitly under a 10b5-1 plan, it is less likely to reflect new, non-public negative information.

02

Market read

A completed insider sale is reported; near-term trading impact is likely small absent other catalysts.

03

What to watch

The filing doesn’t indicate whether additional sales occurred around the same period, nor does it reveal tax/portfolio-rebalancing motives; interpret cautiously.

Relevance 6/10Novelty 6/10Timing: Filed/dated for sale on 2026-06-03 (disclosed 2026-06-04)

Background

This is an SEC Form 4 insider transaction disclosure for Rubrik, Inc. (RBRK), reported as an open-market sale by the CTO under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$RBRKNeutralMedium confidence
Context

Rubrik CTO Nithrakashyap Arvind sold 5,655 shares in an open-market transaction worth about $449,912 under a pre-arranged 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect would be sentiment/flow-related rather than fundamental.

Evidence & confidence

Form 4 provides a completed sale datapoint, yet it explicitly references a pre-arranged 10b5-1 plan, which typically dampens interpretability as a reaction to new company-specific news.

Market effects

Minimal—single-company insider transaction without accompanying operational/financial catalyst.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can still coincide with valuation/positioning decisions and may weigh on short-term sentiment.

Key entities

  • Rubrik, Inc.

    Subject of the insider transaction disclosure (Form 4).

  • Nithrakashyap Arvind

    Chief Technology Officer who sold 5,655 shares.

  • 10b5-1 plan

    Pre-arranged trading plan that reduces inference about timing relative to new information.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RBRKMed

Here's How Rubrik Stock Gained 28.6% Last Month

Rubrik (RBRK) rose 28.6% in August 2026, driven by a cybersecurity rally and strong earnings. Q2 2027 earnings showed a profit of $0.20 per share and 41% revenue growth. The stock trades at 12.7x sales and 68x free cash flow, with analysts calling the post-earnings drop a buying opportunity. The company's growth and market position make it appealing despite its high valuation and volatility.

$RBRKMed

Jim Cramer on Rubrik (RBRK): “It Just Came in Maybe Too Hot”

Rubrik, Inc. (RBRK) reported Q2 fiscal 2027 revenue of $427.3M, up 38% YoY, beating estimates. EPS was $0.20, above consensus. Subscription ARR rose 33% to $1.66B. Guidance was raised. Despite strong results, shares dropped 13% post-earnings, possibly due to high expectations. Free cash flow grew 14% YoY, but margins declined. Hedge fund holdings decreased slightly, and short interest is around 9%.

$RBRKMed

Rubrik’s AI Security Bet Could Power the Next Leg Higher

Rubrik reported Q2 earnings with adjusted EPS of $0.20, beating estimates by $0.16. Revenue and earnings guidance exceeded expectations. Analysts raised price targets, with a consensus near pre-release highs. Institutional investors have been accumulating shares. Risks include high valuation and competition, notably from Microsoft. The company expects GAAP profitability by 2028.